Hexagon Capital Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-703
| Closed | -$243K | – | 774 |
|
|
2025
Q1 | $243K | Buy |
703
+95
| +16% | +$32.8K | 0.05% | 187 |
|
|
2024
Q4 | $182K | Sell |
608
-2
| -0.3% | -$600 | 0.03% | 232 |
|
|
2024
Q3 | $248K | Sell |
610
-3
| -0.5% | -$1.22K | 0.05% | 180 |
|
|
2024
Q2 | $197K | Sell |
613
-4
| -0.6% | -$1.29K | 0.04% | 204 |
|
|
2024
Q1 | $206K | Buy |
617
+2
| +0.3% | +$667 | 0.05% | 201 |
|
|
2023
Q4 | $166K | Buy |
615
+6
| +1% | +$1.62K | 0.04% | 222 |
|
|
2023
Q3 | $150K | Buy |
609
+9
| +2% | +$2.21K | 0.04% | 209 |
|
|
2023
Q2 | $182K | Hold |
600
| – | – | 0.05% | 176 |
|
|
2023
Q1 | $158K | Hold |
600
| – | – | 0.04% | 183 |
|
|
2022
Q4 | $144K | Hold |
600
| – | – | 0.04% | 191 |
|
|
2022
Q3 | $110K | Sell |
600
-291
| -33% | -$53.4K | 0.03% | 224 |
|
|
2022
Q2 | $150K | Sell |
891
-67
| -7% | -$11.3K | 0.04% | 198 |
|
|
2022
Q1 | $240K | Buy |
958
+92
| +11% | +$23K | 0.06% | 161 |
|
|
2021
Q4 | $223K | Sell |
866
-33
| -4% | -$8.5K | 0.06% | 169 |
|
|
2021
Q3 | $218K | Buy |
899
+34
| +4% | +$8.25K | 0.06% | 151 |
|
|
2021
Q2 | $179K | Buy |
865
+65
| +8% | +$13.5K | 0.05% | 161 |
|
|
2021
Q1 | $150K | Hold |
800
| – | – | 0.04% | 167 |
|
|
2020
Q4 | $131K | Hold |
800
| – | – | 0.04% | 159 |
|
|
2020
Q3 | $104K | Buy |
+800
| New | +$104K | 0.03% | 172 |
|